46
Views
40
CrossRef citations to date
0
Altmetric
Original Article

Insulin-like growth factor-I (IGF-I) Stimulates regrowth of the damaged intestine in rats, when administered following, but not concurrent with, methotrexate

, , , &
Pages 279-292 | Received 27 Oct 1997, Accepted 11 Dec 1997, Published online: 21 Aug 2009

References

  • Bastian S. E. P., Walton P. E., Wallace J. C., Ballard F. J. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats. J. Endocrinol. 1993; 138: 327–336
  • Baxter R. C., Martin J. L. Binding proteins for the insulin-like growth factors, structure, regulation and function. Prog. Growth Factor Res 1989a; 1: 49–68
  • Baxter R. C., Martin J. L. Structure of the M1, 140,000 growth hormone-dependent insulin-like growth factor binding protein complex determination by reconstitution and affinity labelling. Proc. Nat. Acad. Sci. USA 1989b; 86: 6898–6902
  • Corazza G. R., Frazzoni M., Dixon M. F., Gasbarrini G. Quantitative assessment of the mucosal architecture of jejunal biopsy specimens: comparison between linear measurement, stereology, and computer aided microscopy. J. Clin. Pathol. 1985; 8: 765–770
  • Davies S. C., Wass J. A. H., Ross R. J. M., Cotterill A. M., Buchanan C. R., Coulson V. J., Holly J. M. P. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J. Endocrinol. 1991; 130: 469–473
  • Hirano M., Iwakiri R., Fujimoto K., Sakata H., Ohyama T., Sakai T., Joh T., Itch M. Epidermal growth factor enhances repair of rat intestinal mucosa damaged by oral administration of methotrexate. J. Gastroenterology 1995; 30(2)169–176
  • Hossenlopp P., Segovia B., Lassarre C., Roghani M., Bredon M., Bonoux M. Evidence of enzymatic degradation of insulin-like growth factor binding proteins in the 150K complex during pregnancy. J Clin. Endocrinol. Metab 1990; 71: 797–805
  • Howarth G. S., Francis G. L., Cool J. C., Xu X., Byard R. W., Read L. C. Milk growth factors enriched from cheese whey ameliorate intestinal damage by methotrexate when administered orally to rats. J. Nutrition 1996; 126(10)2519–2530
  • Jolivet J., Cowan J. H., Curt G. A., Clendennin N. J., Charner B. A. The pharmacology and clinical use of methotrexate. N. Engl. J. Med. 1983; 309: 1094–1104
  • Lemmey A. B., Martin A. A., Read L. C., Tomas F. M., Owens P. C., Ballard F. J. IGF-1 and the truncated analogue des-(1–3) IGF-I enhance growth in rats after gut resection. Am J Physiol. 1991; 260: E213–219
  • McCormack E. S., Borzillo G. V., Ambrosino C., Mak G., Hamablet L., Qu G. Y., Haley J. D. Transforming growth factor-beta 3 protection of epithelial cells from cycle-selective chemotherapy in vitro. Biochem-Pharmacol. 1997; 53(8)1149–1159
  • Owens P. C., Johnson R. J., Campbell R. G., Ballard F. J. Growth hormone increases insulin-like growth factor-I (IGF-I) and decreases IGF-II in plasma of growing pigs. J. Endocrinol. 1990; 124: 269–275
  • Petschow B. W., Carter D. L., Hutton G. D. Influence of orally administered epidermal growth factor on normal and damaged intestinal mucosa in rats. J. Pediatric. Gastroent. Nutr 1993; 17: 49–58
  • Read L. C., Tomas F. M., Howarth G. S., Martin A. A., Edson K. J., Gillespie C. M., Ballard F. J. Insulin-like growth factor-1 and its N-terminal modified analogues induce gut growth in dexamethasone-treated rats. J. Endocrinol 1992; 133(3)421–431
  • Saxena S. K., Thompson J. S., Sharp J. G. Role of epidermal growth factor in intestinal regeneration. Surgery 1992; 111: 318–325
  • Sonis S. T., Costa J. W., Jr, Evitts S. M., Lindquist L. E., Nicholson M. Effect of epidermal growth factor on ulcerative mucositis in hamsters that receive chemotherapy. Oral Surg. Oral Med. Oral Pathol 1992; 74: 749–755
  • Sonis S. T., Lindquist L., Van-Vugt A., Stewart A. A., Stam K., Qu G. Y., Iwata K. K., Haley J. D. Prevention of chemotherapy-induced ulcerative mucositis by transforming growth factor beta 3. Cancer Res. 1994; 54(5)1135–1138
  • Sonis S. T., Van-Vugt A. G., Brien J. P., Muska A. D., Bruskin A. M., Rose A., Haley J. D. Transforming growth factor-beta 3 mediated modulation of cell cycling and attenuation of 5-fluorouracil induced oral mucositis. Oral Oncol. 1997; 33(1)47–54
  • Steeb C.-B., Trahair J. F., Tomas F. M., Read L. C. Prolonged administration of IGF peptides enhances growth of gastrointestinal tissues in normal rats. Am. J. Physiol. 1994; 266: G1090–1098, (6 Pt 1)
  • Steeb C.-B., Trahair J. F., Read L. C. Administration of insulin-like growth factor-I (IGF-I) peptides for three days stimulates proliferation of the small intestinal epithelium in rats. Gut 1995; 37: 630–638
  • Tomas F. M., Knowles S. E., Owens P. C., Read L. C., Chandler C. S., Gargosky S. E., Ballard F. J. Increased weight gain, nitrogen retention and muscle protein synthesis following treatment of diabetic rats with insulin-like growth factor-I and des(1–3) IGF-I. Biochem. J. 1991a; 276(2)547–554
  • Tomas F. M., Knowles S. E., Owens P. C., Read L. C., Chandler C. S., Gargosky S. E., Ballard F. J. Effects of full-length and truncted insulin-like growth factor-I on nitrogen balance and mudcle metabolism in nitrogen-restricted rats. J. Endocrinol 1991b; 128: 97–105
  • Tomas F. M., Knowles S. E., Owens P. C., Chandler C. S., Francis G. L., Read L. C., Ballard F. J. Insulin-like growth factor-1 (IGF-I) and especially variants are anabolic in dexamethasone-treated rats. J. Biochem. 1992; 282: 91–97
  • Young S. C. J., Underwood L. E., Celinker A., Clemmons D. R. Effects of recombinant insulin-like growth factor-I (IGF-I) and growth hormone on serum IGF-binding proteins in calorically restricted adults. J Clin Endocrinol Metab 1992; 75: 603–608
  • Vanderhoof J. A., Park J. H., Mohammadpour H., Black-Wood D. Effects of dietary lipids on recovery from mucosal injury. Gastroenterology 1990; 8: 1226–1231
  • Zapf J., Hauri C., Waldvagel M., Futo E., Häsler H., Binz K., Guler H. P., Schmid C., Froesch E. R. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 3813–3817

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.